130 related articles for article (PubMed ID: 30487132)
1. Whole-Blood DNA Methylation Markers in Early Detection of Breast Cancer: A Systematic Literature Review.
Guan Z; Yu H; Cuk K; Zhang Y; Brenner H
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):496-505. PubMed ID: 30487132
[TBL] [Abstract][Full Text] [Related]
2. Blood-based DNA methylation as biomarker for breast cancer: a systematic review.
Tang Q; Cheng J; Cao X; Surowy H; Burwinkel B
Clin Epigenetics; 2016; 8():115. PubMed ID: 27895805
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
[TBL] [Abstract][Full Text] [Related]
4. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
5. Epigenome-wide DNA methylation and risk of breast cancer: a systematic review.
Ennour-Idrissi K; Dragic D; Durocher F; Diorio C
BMC Cancer; 2020 Oct; 20(1):1048. PubMed ID: 33129307
[TBL] [Abstract][Full Text] [Related]
6. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
[TBL] [Abstract][Full Text] [Related]
7. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study.
Brooks JD; Cairns P; Shore RE; Klein CB; Wirgin I; Afanasyeva Y; Zeleniuch-Jacquotte A
Cancer Epidemiol; 2010 Dec; 34(6):717-23. PubMed ID: 20627767
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
[TBL] [Abstract][Full Text] [Related]
10. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
Heiss JA; Brenner H
Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
[TBL] [Abstract][Full Text] [Related]
11. Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature.
Gonzalez T; Nie Q; Chaudhary LN; Basel D; Reddi HV
Cancer Genet; 2024 Apr; 282-283():1-8. PubMed ID: 38134587
[TBL] [Abstract][Full Text] [Related]
12. Whole-blood DNA Methylation Markers for Risk Stratification in Colorectal Cancer Screening: A Systematic Review.
Raut JR; Guan Z; Schrotz-King P; Brenner H
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31261771
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review.
Xue M; Lai SC; Xu ZP; Wang LJ
J Dig Dis; 2015 Dec; 16(12):699-712. PubMed ID: 26565661
[TBL] [Abstract][Full Text] [Related]
14. The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies.
Yang R; Stöcker S; Schott S; Heil J; Marme F; Cuk K; Chen B; Golatta M; Zhou Y; Sutter C; Wappenschmidt B; Schmutzler R; Bugert P; Qu B; Bartram CR; Sohn C; Schneeweiss A; Burwinkel B
Carcinogenesis; 2017 Mar; 38(3):312-320. PubMed ID: 28426874
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation-based biomarkers in serum of patients with breast cancer.
Van De Voorde L; Speeckaert R; Van Gestel D; Bracke M; De Neve W; Delanghe J; Speeckaert M
Mutat Res; 2012; 751(2):304-325. PubMed ID: 22698615
[TBL] [Abstract][Full Text] [Related]
16. A plasma metabolite panel as biomarkers for early primary breast cancer detection.
Yuan B; Schafferer S; Tang Q; Scheffler M; Nees J; Heil J; Schott S; Golatta M; Wallwiener M; Sohn C; Koal T; Wolf B; Schneeweiß A; Burwinkel B
Int J Cancer; 2019 Jun; 144(11):2833-2842. PubMed ID: 30426507
[TBL] [Abstract][Full Text] [Related]
17. Improving early breast cancer detection: focus on methylation.
Suijkerbuijk KPM; van Diest PJ; van der Wall E
Ann Oncol; 2011 Jan; 22(1):24-29. PubMed ID: 20591821
[TBL] [Abstract][Full Text] [Related]
18. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
[TBL] [Abstract][Full Text] [Related]
19. Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer.
Shan M; Yin H; Li J; Li X; Wang D; Su Y; Niu M; Zhong Z; Wang J; Zhang X; Kang W; Pang D
Oncotarget; 2016 Apr; 7(14):18485-94. PubMed ID: 26918343
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.
Visvanathan K; Fackler MS; Zhang Z; Lopez-Bujanda ZA; Jeter SC; Sokoll LJ; Garrett-Mayer E; Cope LM; Umbricht CB; Euhus DM; Forero A; Storniolo AM; Nanda R; Lin NU; Carey LA; Ingle JN; Sukumar S; Wolff AC
J Clin Oncol; 2017 Mar; 35(7):751-758. PubMed ID: 27870562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
